Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on PBRM1
Total 1 results
Lynkcell Europe
Available
An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF)
Kidney Cancer | Clear Cell Kidney Cancer | Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations
Sponsors and Collaborators
The Fifth Affiliated Hospital of Zunyi Medical College
Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
ProteoSys AG
Celtaxsys Aus Pty Limited
Diego Hernan Giunta, MD
Elim Pediatric Pharmaceuticals Inc.
CRMBM-CEMEREM
Donders Institute for Brain, Cognition and Behavior
Alberta Children's Hospital, Calgary, Canada
Fondren Orthopedic Group L.L.P.
San MediTech(Huzhou)Co.,Ltd.
Rui-hua Xu, MD, PhD
AMTC & Associates
University Medical Center Goettingen
University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
Caritas Freetown
Societa Italiana di Endoscopia Digestiva
Norsk Proteinintolerance, Norway
Cardresearch
Victor Montori
View Full List
Medical Conditions
Tularaemia
Prostate Cancer Recurrent
Non-compressible Torso Hemorrhage
Normal Diameter of Optic Nerve
Disturbance of Activity and Attention
Orbital Tumor
Postcomatose Unawareness State
Gynecologic Cancer
Fever, Sweats, and Hot Flashes
Auditory Hallucination, Verbal
Tube Disorders Eustachian
Fibromyalgia Syndrome, Primary
Non-dystrophic Myotonias
Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
Lymphedema of Arm
Plasmodium Falciparum Malaria (Drug Resistant)
Atrial Fibrillation, Postoperative
Malignant Ascites Due to Epithelial Carcinoma
Spermatogenesis Arrest
Stereotactic Radioablation for Ventricular Tachycardia
View Full List
Drug Interventions
Flibanserin 100 mg dose every evening
Atezolizumab
Bortezomib/dexamethasone
Indoximod
Lamivudine
Ruxolitinib
SERETIDE Diskus
Enzalutamide, Abiraterone
Cytarabine ARA-C
Polyethylene glycol 3350
Insulin
PF-00868554
Epimedium Prenylflavonoids Extract
Cetrorelix 78 mg + 78 mg
Mupirocin Calcium
Topotecan
CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
Oxycodone, fentanyl
HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
Methotrexate
View Full List
CROs by country
Contract Research Organizations in Bahamas
Contract Research Organizations in Bosnia & Herzegovina
Contract Research Organizations in Burkina Faso
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Gambia
Contract Research Organizations in Germany
Contract Research Organizations in Italy
Contract Research Organizations in Liberia
Contract Research Organizations in Madagascar
Contract Research Organizations in Mauritania
Contract Research Organizations in Mongolia
Contract Research Organizations in Tanzania
Contract Research Organizations in Vietnam
CRO list by country
CROs in Macedonia
Comac Medical
IQVIA
ZEINCRO
BiTrial Clinical Research
Clinres Farmacija
All CROs in Macedonia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe